ARDX
Price
$5.97
Change
+$0.13 (+2.23%)
Updated
Aug 15 closing price
Capitalization
1.44B
74 days until earnings call
MAIA
Price
$1.58
Change
+$0.02 (+1.28%)
Updated
Aug 15 closing price
Capitalization
52.13M
One day until earnings call
Interact to see
Advertisement

ARDX vs MAIA

Header iconARDX vs MAIA Comparison
Open Charts ARDX vs MAIABanner chart's image
Ardelyx
Price$5.97
Change+$0.13 (+2.23%)
Volume$4.61M
Capitalization1.44B
MAIA Biotechnology
Price$1.58
Change+$0.02 (+1.28%)
Volume$93.76K
Capitalization52.13M
ARDX vs MAIA Comparison Chart in %
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARDX vs. MAIA commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Hold and MAIA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (ARDX: $5.97 vs. MAIA: $1.58)
Brand notoriety: ARDX and MAIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 103% vs. MAIA: 20%
Market capitalization -- ARDX: $1.44B vs. MAIA: $52.13M
ARDX [@Biotechnology] is valued at $1.44B. MAIA’s [@Biotechnology] market capitalization is $52.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileMAIA’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • MAIA’s FA Score: 0 green, 5 red.
According to our system of comparison, ARDX is a better buy in the long-term than MAIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 4 TA indicator(s) are bullish while MAIA’s TA Score has 6 bullish TA indicator(s).

  • ARDX’s TA Score: 4 bullish, 4 bearish.
  • MAIA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MAIA is a better buy in the short-term than ARDX.

Price Growth

ARDX (@Biotechnology) experienced а +14.59% price change this week, while MAIA (@Biotechnology) price change was +3.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

ARDX is expected to report earnings on Oct 30, 2025.

MAIA is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARDX($1.44B) has a higher market cap than MAIA($52.1M). ARDX YTD gains are higher at: 17.751 vs. MAIA (-20.202). MAIA has higher annual earnings (EBITDA): -24.75M vs. ARDX (-28.23M). ARDX has more cash in the bank: 214M vs. MAIA (10.9M). ARDX has higher revenues than MAIA: ARDX (362M) vs MAIA (0).
ARDXMAIAARDX / MAIA
Capitalization1.44B52.1M2,762%
EBITDA-28.23M-24.75M114%
Gain YTD17.751-20.202-88%
P/E RatioN/AN/A-
Revenue362M0-
Total Cash214M10.9M1,963%
Total Debt155MN/A-
FUNDAMENTALS RATINGS
ARDX: Fundamental Ratings
ARDX
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
44
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARDXMAIA
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 5 days ago
88%
Declines
ODDS (%)
Bearish Trend 20 days ago
81%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NGJIX18.900.07
+0.37%
Nuveen Global Real Estate Securities I
MWEFX47.350.15
+0.32%
MFS Global Equity A
HBLIX14.93-0.01
-0.07%
Hartford Balanced Income I
SSDSX36.44-0.08
-0.22%
DWS Small Cap Growth S
PQSCX24.24-0.33
-1.34%
Virtus KAR Small-Cap Value C

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with RIGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
+2.23%
RIGL - ARDX
37%
Loosely correlated
+4.28%
CSCI - ARDX
35%
Loosely correlated
-18.57%
PCVX - ARDX
34%
Loosely correlated
+4.04%
MYNDF - ARDX
33%
Loosely correlated
N/A
MAIA - ARDX
31%
Poorly correlated
+1.28%
More

MAIA and

Correlation & Price change

A.I.dvisor tells us that MAIA and ARDX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAIA and ARDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
+1.28%
ARDX - MAIA
31%
Poorly correlated
+2.23%
IPSC - MAIA
31%
Poorly correlated
+2.15%
TERN - MAIA
28%
Poorly correlated
+4.14%
RZLT - MAIA
28%
Poorly correlated
+0.62%
JBIO - MAIA
27%
Poorly correlated
+8.71%
More